Armando Orlandi/photos.asco.org
Feb 19, 2025, 09:07
Armando Orlandi: Metabolic markers predict response and recurrence in Breast Cancer
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared an article by Carla Oliveira, et al. on X:
“Cowabunga!
Riding Breast Cancer’s Biggest Data’s Wave from Literature.
PET/CT study drops major knowledge: metabolic markers predict response & recurrence in BC!
Tumor & lymphoid parameters surfing the waves of precision medicine.”
Baseline [18F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy.
Authors: Carla Oliveira, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 11:00
Sep 8, 2025, 10:52
Sep 8, 2025, 09:53
Sep 8, 2025, 09:46
Sep 8, 2025, 09:06
Sep 8, 2025, 08:57